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Appendix 
Epidemiologic Investigation 
The patient’s farm is located in the Department of Cundinamarca, Colombia. It 
comprised ~120 ha and contained >120 cows for milk and meat production; milking was 
performed manually without the routine use of gloves. Interviews with three farmworkers 
(excluding the patient described) and one family member did not reveal any active illness or 
recent history of lesions. Farmworkers reported seeing lesions on the udders and teats of multiple 
cows (15 out of 35 milking cows) during the time when the patient development lesions. No 
active lesions were identified during examination of the farm’s domestic animals in September 
2015. 
Serologic Tests 
Anti-orthopoxvirus antibodies were determined by enzyme-linked immunosorbent assays 
(ELISA) from patient (IgM and IgG) and animal (IgG) sera (1). Serum samples from the patient 
were diluted 1:100 for IgG assays and 1:50 for IgM; cutoff values were determined based on the 
mean plus three standard deviations of negative control serum samples. Additionally, 
neutralization assay was performed using a Western Reserve Vaccinia virus which expresses the 
green fluorescent protein (WR-GFP) (2); Effective Concentration (EC50) values were calculated 
for each sample. 
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Viral Isolation 
BSC-40 cells were grown in RPMI medium supplemented with 5% fetal bovine serum 
and 500 U/mL penicillin; and 50 mg/mL gentamicin. Fresh cultures were inoculated with the 
biologic sample and the cytopathic effect was observed 6 days after inoculation. 
Molecular Characterization 
Samples from crusts, swabs, specimens from cutaneous lesions were used for molecular 
diagnosis and viral culture. DNA was extracted from original samples using DNeasy Blood & 
Tissue Kit (Qiagen). Forward and reverse primers for detecting poxviruses with low GC content 
(including Orthopoxvirus) were used for PCR amplification of a short DNA fragment of ≈220 bp 
(3). Additionally, DNA fragments containing the B5R (1130 bp) with the primers designed by 
Usme-Ciro (Unpublished) Primers B5R_F (5′-ccttttagtgctcgacagtg-3′), B5R_R (5′-
atgctctaacggcatcgtag-3′). and A56R genes (Hemagglutinin, 1134 bp) of VACV were amplified 
(4). OPXV-generic qPCR infection was confirmed by OPXV-generic qPCR (E9L non-variola 
assay) (5) and VACV-specific PCR assay from CDC. 
Phylogenetic Analysis 
DNA sequences from amplicons for A56R gene were obtained using the Applied 
Biosystems 3130 Genetic Analyzer and the BigDye® Terminator Cycle Sequencing kit v.3.1 
(Applied Biosystems, Foster City, CA, USA). Sequences were subsequently assembled through 
the SeqMan module of the LaserGene® version 7.2.1 (DNASTAR Inc. Madison, WI, USA). 
Sequences obtained from lesion samples (POX009) were aligned with published A56R gene 
sequences of VACV using ClustalX2.1 software (6). Aligned sequences were used to calculate 
the best nucleotide substitution model (HKY + gamma) through BIC implemented in jModeltst 
2.1.3 software (7). Phylogenetic inference was performed with the use of the Bayesian analysis 
software packages BEAST BEAUti, version 1.8.4 (8) and Tracer v1.6 (9). The analyses ran a 
Markov chain Monte Carlo chain length of 10.000.000 and sampling of every 1000 states, with a 
lognormal relaxed molecular clock (Appendix Figure). 
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Appendix Figure. HIV viral load and absolute CD4+ count during VACV infection. Changes in HIV load 
(blue line) and absolute CD4+ counts (pink line) between July 2014 and February 2016. Purple lines 
indicate the duration of VACV infection. Gray lines indicate sample collection for OPXV diagnosis. OPX 
PCR: Orthopoxvirus PCR test; IgG: Anti-orthopox IgG antibodies; IgM: Anti-orthopox IgM antibodies; 
Culture: Viral culture in green monkey kidney cells (BSC40). 
